Ascent Solar to Introduce WaveSol Series Exclusively for its BIPV-BAPV Segment

Ascent Solar Technologies, Inc., a pliant thin-film photovoltaic modules developing company, has declared the introduction of its new patented WaveSol series of five meter long solar modules that efficiently matches with its building integrated (BIPV) and building applied (BAPV) type of photovoltaic products.

Thin Film PV Module

The new WaveSol WSLB 3200-190 is a flexible CIGS module of 5.0 m x 0.6 m size with a capability to produce up to 320 W, voltage up to 190 V and 50 W/kg specific power. The new products incorporate the recent advancements made in the CIGS monolithic integration process technologies of the company that resulted in the construction of large 30 cm x 60 cm building blocks that are four times bigger in size than the currently available building block sub-modules. The newly introduced modules incorporate less number of parts to reduce internal power losses and to considerably reduce the number of functions involved in production and testing. The product is exclusively designed for use in large scale commercial level roof top installations with exclusive inputs to lessen the BOS costs, and for easy assimilation with the roofing structure. The company is planning to introduce the product during the proposed Solar Power International conference to be held in Los Angeles California.

Farhad Moghadam, President and CEO of Ascent Solar, said that his company feels proud about its flexible CIGS solar modules. He added that his company is looking forward to retain its current status as the leading manufacturer of low- weight CIGS modules for BIPV/BAPV requirements by improving its module efficiencies and making it a cost effective solar installation solution.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.